Atrovet binds to and inhibit muscarinic acetylcholine receptors, producing a wide range of anticholinergic effects. Atrovet is an anticholinergic agent which competitively blocks the muscarinic receptors in peripheral tissues such as the heart, intestines, bronchial muscles, iris and secretory glands. Some central stimulation may occur. Atrovet abolishes bradycardia and reduces heart block due to vagal activity. Smooth muscles in the bronchi and gut are relaxed while glandular secretions are reduced. It also has mydriatic and cycloplegic effect.
Atrovet is used for Non ulcer dyspepsia, Irritable bowel syndrome, Diverticular disease, Bradycardia, Organophosphorus poisoning, Premedication in anesthesia, Poisoning or overdosage with compound having muscarinic actions, Ophthalmic Inflammatory eye disorders, Eye refraction.
Atrovet is also used to associated treatment for these conditions: Amblyopia, Atrioventricular Heart Block, Bradycardia, Bronchospasm, Crying, Detrusor Hyperreflexia, Excessive bronchial secretion, Hypertonic uterine contraction, Hypertonicity of the small intestine, Ocular Inflammation, Parkinsonism, Peptic Ulcer, Poisoning by parasympathomimetics (cholinergics), Poisoning caused by mushrooms, Poisoning caused by organophosphate anticholinesterase nerve agents, Poisoning caused by organophosphorus pesticides, Pylorospasm, Rhinorrhoea, Sinus Bradycardia, Spasms, Toxic effect of organophosphate and carbamate, Hypermobility of the colon, Laughing, Muscarinic side effects
|Other Names||Atropin, Atropina, Atropine, Atropinum, dl-Hyoscyamine, dl-tropyltropate, Tropine tropate|
The protein binding of atropine is 14 to 22% in plasma.
|Therapeutic Class||Anticholinergics (antimuscarinics)/ Anti-spasmodics, Mydriatic and Cycloplegic agents|
|Manufacturer||Techno Drugs Ltd|
|Last Updated:||June 23, 2021 at 11:16 am|
Table Of contents
- IV: Bradycardia: 500 mcg every 3-5 mins. Total: 3 mg.
- IV/IM: Organophosphorus poisoning: 2 mg every 10-30 mins until muscarinic effects disappear or atropine toxicity appears.
- IM/SC: Premedication in anesthesia: 300-600 mcg 30-60 mins before anesthesia.
- IV/IM/SC: Poisoning or overdosage with compound having muscarinic actions: 0.6-1 mg, repeat 2 hrly.
- Ophthalmic: Inflammatory eye disorders: As 0.5-1% solution: 1-2 drops 4 times/day.
- Ophthalmic: refraction: 1% solution 1 drop twice daily for 1-2 days before procedure.
- Oral: Non ulcer dyspepsia, Irritable bowel syndrome, Diverticular disease: 0.6-1.2 mg as a single dose at bedtime.
Usual Pediatric Dose for Anesthesia:
- 7 to 16 pounds: 0.1 mg, IV, IM, or subcutaneously
- 17 to 24 pounds: 0.15 mg, IV, IM, or subcutaneously
- 24 to 40 pounds: 0.2 mg, IV, IM, or subcutaneously
- 40 to 65 pounds: 0.3 mg, IV, IM, or subcutaneously
- 65 to 90 pounds: 0.4 mg, IV, IM, or subcutaneously
- Over 90 pounds: 0.4 to 0.6 mg, IV, IM, or subcutaneously
Injection: Dry mouth, dysphagia, constipation, flushing and dryness of skin, tachycardia, palpitations, arrhythmias, mydriasis, photophobia, cycloplegia, raised intraocular pressure. Toxic doses cause tachycardia, hyperpyrexia, restlessness, confusion, excitement, hallucinations, delirium and may progress to circulatory failure and resp depression.
Eye drops or ointment: Systemic toxicity esp in children, on prolonged use may lead to irritation, hyperaemia, oedema and conjunctivitis. Increased intraocular pressure.
Reflux oesophagitis; elderly; infants and children; Pregnancy.
Additive anticholinergic effects with quinidine, antidepressants and some antihistamines.
- Avoid alcohol.
- Take with food.
3.0 ± 0.9 hours in adults. The half-life of atropine is slightly shorter (approximately 20 minutes) in females than males.
Pregnancy & Breastfeeding use
Pregnancy Category C. Animal reproduction studies have not been conducted with atropine. It also is not known whether atropine can cause fetal harm when given to a pregnant woman or can affect reproduction capacity. Atrovet should be given to a pregnant woman only if clearly needed.
Glaucoma, chronic respiratory disease, sick sinus syndrome, thyrotoxicosis, cardiac failure, pyloric stenosis, prostatic hypertrophy.
May cause hyperthermia, hypertension, increased respiratory rate, nausea and vomiting. May also lead to CNS stimulation. Severe intoxication may lead to CNS depression, coma, respiratory failure and death.
Store atropine at room temperature between 20 to 25° C. Store away from heat, moisture, and light. Keep atropine out of the reach of children.